| Edward J Macinerney, MD | |
|
700 W Ironwood Dr Ste 320, Coeur D Alene, ID 83814-4485 | |
| (208) 625-5250 | |
| (208) 625-5251 |
| Full Name | Edward J Macinerney |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 35 Years |
| Location | 700 W Ironwood Dr Ste 320, Coeur D Alene, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053375105 | NPI | - | NPPES |
| 27025013 | Other | MO | BCBS-KC |
| 060060916 | Other | MO | RAILROAD MEDICARE |
| 20007804 | Other | MEDICARE | |
| 1053375105 | Medicaid | ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | M-13060 (Idaho) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kootenai Health | Coeur d'alene, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kootenai Health Inc | 1355792276 | 291 |
| Kootenai Health, Inc. | 4789641598 | 331 |
News Archive
The U.S. Food and Drug Administration has approved a humanitarian device exemption for the first implantable device that delivers intermittent electrical therapy deep within the brain to suppress the symptoms associated with severe obsessive-compulsive disorder (OCD).
Gas-related symptoms are associated with poorer quality of life, and higher stress, anxiety, and depression, with breaking wind being the most frequently reported gas issue, affecting eight out of 10 adults in the general population (81.3 %) in a 24-hour period, according to a new survey1 being presented today at UEG Week Virtual 2021.
Researchers from Boston University School of Medicine (BUSM) are recommending that menopausal women on hormone therapy (HT) continue their treatment prior to having their annual mammogram screenings. These recommendations appear as an editorial in the current on-line issue of Journal of the North American Menopause Society.
The Prix Galien USA committee honored innovations that are saving lives last night during the Prix Galien Awards Gala. The Pro Bono Humanum Award, the Prix Galien USA 2010 and the Prix Galien International were presented and related accomplishments celebrated.
› Verified 9 days ago
| Entity Name | Kootenai Health, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235288655 PECOS PAC ID: 4789641598 Enrollment ID: O20041214000230 |
News Archive
The U.S. Food and Drug Administration has approved a humanitarian device exemption for the first implantable device that delivers intermittent electrical therapy deep within the brain to suppress the symptoms associated with severe obsessive-compulsive disorder (OCD).
Gas-related symptoms are associated with poorer quality of life, and higher stress, anxiety, and depression, with breaking wind being the most frequently reported gas issue, affecting eight out of 10 adults in the general population (81.3 %) in a 24-hour period, according to a new survey1 being presented today at UEG Week Virtual 2021.
Researchers from Boston University School of Medicine (BUSM) are recommending that menopausal women on hormone therapy (HT) continue their treatment prior to having their annual mammogram screenings. These recommendations appear as an editorial in the current on-line issue of Journal of the North American Menopause Society.
The Prix Galien USA committee honored innovations that are saving lives last night during the Prix Galien Awards Gala. The Pro Bono Humanum Award, the Prix Galien USA 2010 and the Prix Galien International were presented and related accomplishments celebrated.
› Verified 9 days ago
| Entity Name | Kootenai Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174661151 PECOS PAC ID: 1355792276 Enrollment ID: O20240111003252 |
News Archive
The U.S. Food and Drug Administration has approved a humanitarian device exemption for the first implantable device that delivers intermittent electrical therapy deep within the brain to suppress the symptoms associated with severe obsessive-compulsive disorder (OCD).
Gas-related symptoms are associated with poorer quality of life, and higher stress, anxiety, and depression, with breaking wind being the most frequently reported gas issue, affecting eight out of 10 adults in the general population (81.3 %) in a 24-hour period, according to a new survey1 being presented today at UEG Week Virtual 2021.
Researchers from Boston University School of Medicine (BUSM) are recommending that menopausal women on hormone therapy (HT) continue their treatment prior to having their annual mammogram screenings. These recommendations appear as an editorial in the current on-line issue of Journal of the North American Menopause Society.
The Prix Galien USA committee honored innovations that are saving lives last night during the Prix Galien Awards Gala. The Pro Bono Humanum Award, the Prix Galien USA 2010 and the Prix Galien International were presented and related accomplishments celebrated.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Edward J Macinerney, MD 2003 Kootenai Health Way, Coeur D Alene, ID 83814-6051 Ph: (208) 625-5250 | Edward J Macinerney, MD 700 W Ironwood Dr Ste 320, Coeur D Alene, ID 83814-4485 Ph: (208) 625-5250 |
News Archive
The U.S. Food and Drug Administration has approved a humanitarian device exemption for the first implantable device that delivers intermittent electrical therapy deep within the brain to suppress the symptoms associated with severe obsessive-compulsive disorder (OCD).
Gas-related symptoms are associated with poorer quality of life, and higher stress, anxiety, and depression, with breaking wind being the most frequently reported gas issue, affecting eight out of 10 adults in the general population (81.3 %) in a 24-hour period, according to a new survey1 being presented today at UEG Week Virtual 2021.
Researchers from Boston University School of Medicine (BUSM) are recommending that menopausal women on hormone therapy (HT) continue their treatment prior to having their annual mammogram screenings. These recommendations appear as an editorial in the current on-line issue of Journal of the North American Menopause Society.
The Prix Galien USA committee honored innovations that are saving lives last night during the Prix Galien Awards Gala. The Pro Bono Humanum Award, the Prix Galien USA 2010 and the Prix Galien International were presented and related accomplishments celebrated.
› Verified 9 days ago
Diana Johns, Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 2248 W Rosebud Ln, Coeur D Alene, ID 83814 Phone: 907-687-6248 | |
Marc Olav Granrud, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2003 Kootenai Health Way, Coeur D Alene, ID 83814 Phone: 208-625-6900 Fax: 208-625-6710 | |
Kevin Nathaniel Brown, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 2003 Kootenai Health Way, Coeur D Alene, ID 83814 Phone: 208-625-6900 Fax: 208-625-6910 | |
Dr. Amanda Rose Liggett, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 700 W Ironwood Dr Ste 378, Coeur D Alene, ID 83814 Phone: 208-625-3555 Fax: 208-765-1494 | |
Dr. Robert Scoggins, M.D., PH.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 700 W Ironwood Dr Ste 378, Coeur D Alene, ID 83814 Phone: 208-765-1252 Fax: 208-765-1494 | |
Dr. Sean Tristan Lawrence Cook, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2120 W Ironwood Center Dr, Coeur D Alene, ID 83814 Phone: 208-625-6944 Fax: 208-625-6945 |